Erythromycin Ethylsuccinate 71209-0103-21

Package NDC

71209-0103-21

Manufacturer: Cadila Pharmaceuticals Limited
Dosage Form: For Suspension
Route: Oral
Product Type: Human Prescription Drug
Marketing Start: November 21, 2022
Listing Expires: December 31, 2026
Application: ANDA216212

Need to source Erythromycin Ethylsuccinate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Erythromycin Ethylsuccinate	400 mg/5mL

Drug Class

Decreased Sebaceous Gland Activity [PE]Macrolide Antimicrobial [EPC]Macrolide [EPC]

Selected Package

71209-0103-21Selected

100 mL in 1 BOTTLE (71209-103-21)